622 related articles for article (PubMed ID: 11113208)
1. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
[TBL] [Abstract][Full Text] [Related]
2. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
3. Characterization of steroid receptor coactivator in sea urchin, Strongylocentrotus nudus, and its involvement in embryonic development.
Kim MA; Kim GJ; Maeng S; Jin DH; Sohn YC
Mol Cell Endocrinol; 2011 Jan; 331(1):89-101. PubMed ID: 20816915
[TBL] [Abstract][Full Text] [Related]
4. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators.
Huang N; vom Baur E; Garnier JM; Lerouge T; Vonesch JL; Lutz Y; Chambon P; Losson R
EMBO J; 1998 Jun; 17(12):3398-412. PubMed ID: 9628876
[TBL] [Abstract][Full Text] [Related]
5. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
[TBL] [Abstract][Full Text] [Related]
6. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
7. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
Dutertre M; Smith CL
Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
[TBL] [Abstract][Full Text] [Related]
8. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
[TBL] [Abstract][Full Text] [Related]
9. The coactivator LXXLL nuclear receptor recognition motif.
Savkur RS; Burris TP
J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
[TBL] [Abstract][Full Text] [Related]
10. ERBP, a novel estrogen receptor binding protein enhancing the activity of estrogen receptor.
Bu H; Kashireddy P; Chang J; Zhu YT; Zhang Z; Zheng W; Rao SM; Zhu YJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):54-9. PubMed ID: 15047147
[TBL] [Abstract][Full Text] [Related]
11. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.
Liu J; Knappenberger KS; Kack H; Andersson G; Nilsson E; Dartsch C; Scott CW
Mol Endocrinol; 2003 Mar; 17(3):346-55. PubMed ID: 12554768
[TBL] [Abstract][Full Text] [Related]
12. PNRC2 is a 16 kDa coactivator that interacts with nuclear receptors through an SH3-binding motif.
Zhou D; Chen S
Nucleic Acids Res; 2001 Oct; 29(19):3939-48. PubMed ID: 11574675
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE
Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982
[TBL] [Abstract][Full Text] [Related]
14. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
15. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.
Kobayashi Y; Kitamoto T; Masuhiro Y; Watanabe M; Kase T; Metzger D; Yanagisawa J; Kato S
J Biol Chem; 2000 May; 275(21):15645-51. PubMed ID: 10747867
[TBL] [Abstract][Full Text] [Related]
16. Modulator recognition factor 1, an AT-rich interaction domain family member, is a novel corepressor for estrogen receptor alpha.
Georgescu SP; Li JH; Lu Q; Karas RH; Brown M; Mendelsohn ME
Mol Endocrinol; 2005 Oct; 19(10):2491-501. PubMed ID: 15941852
[TBL] [Abstract][Full Text] [Related]
17. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
Bai Y; Giguére V
Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator.
Ko L; Cardona GR; Chin WW
Proc Natl Acad Sci U S A; 2000 May; 97(11):6212-7. PubMed ID: 10823961
[TBL] [Abstract][Full Text] [Related]
19. Use of suppressor mutants to probe the function of estrogen receptor-p160 coactivator interactions.
Mak HY; Parker MG
Mol Cell Biol; 2001 Jul; 21(13):4379-90. PubMed ID: 11390665
[TBL] [Abstract][Full Text] [Related]
20. Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORgamma.
Kurebayashi S; Nakajima T; Kim SC; Chang CY; McDonnell DP; Renaud JP; Jetten AM
Biochem Biophys Res Commun; 2004 Mar; 315(4):919-27. PubMed ID: 14985100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]